These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8520509)

  • 1. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.
    Hideshima T; Chauhan D; Schlossman R; Richardson P; Anderson KC
    Oncogene; 2001 Jul; 20(33):4519-27. PubMed ID: 11494147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
    Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
    Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
    Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M
    Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
    Kim I; Uchiyama H; Chauhan D; Anderson KC
    Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
    Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
    Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
    Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
    Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
    Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
    Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
    Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
    Lin B; Podar K; Gupta D; Tai YT; Li S; Weller E; Hideshima T; Lentzsch S; Davies F; Li C; Weisberg E; Schlossman RL; Richardson PG; Griffin JD; Wood J; Munshi NC; Anderson KC
    Cancer Res; 2002 Sep; 62(17):5019-26. PubMed ID: 12208756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple myeloma with massive ascites fluid--immunophenotypic analysis of myeloma cell and its IL-6-dependent growth].
    Tatsumi T; Okada M; Yoneda Y; Maki K; Ura Y; Sawada K; Hino R; Goto H; Fujita N; Shimazaki C
    Rinsho Ketsueki; 1994 Dec; 35(12):1361-5. PubMed ID: 7861616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
    Derenne S; Amiot M; Barillé S; Collette M; Robillard N; Berthaud P; Harousseau JL; Bataille R
    J Bone Miner Res; 1999 Dec; 14(12):2048-56. PubMed ID: 10620064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes.
    Jarvis LJ; LeBien TW
    J Immunol; 1995 Sep; 155(5):2359-68. PubMed ID: 7544372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.
    Nakamura S; Kobayashi M; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Hayashi H; Ohnishi K
    Leuk Res; 2006 Feb; 30(2):123-35. PubMed ID: 16046235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.